Vericel (VCEL) Treasury Shares (2012 - 2016)
Vericel's (VCEL) quarterly Treasury Shares came in at $1.2 million in Q4 2015, little changed year-over-year from $1.2 million in Q4 2014, and little changed quarter-over-quarter from $1.2 million in Q4 2014.
Analysis
Vericel (VCEL) Treasury Shares (2012 - 2016) Analysis & Trends
Vericel has disclosed Treasury Shares across 4 years of filings, most recently posting $1.2 million for Q4 2015.
- In Q4 2015, Treasury Shares changed 0.0% year-over-year to $1.2 million; the TTM figure through Dec 2015 stood at $1.2 million (changed 0.0% YoY), while the FY2015 annual figure was $1.2 million, changed 0.0% from the prior year.
- Treasury Shares came in at $3.2 million for Q3 2016 at Vericel, roughly flat from $3.2 million in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $1.2 million in Q4 2014 to a low of $12000.0 in Q1 2012.
- Average Treasury Shares over 4 years is $321500.0, with a median of $12000.0 recorded in 2012.
- The largest YoY upside for Treasury Shares was 0.0% in 2013 against a maximum downside of 0.0% in 2013.
- Over 2 years, Treasury Shares stood at $3.2 million in 2015, then changed by 0.0% to $3.2 million in 2016.
- Per Business Quant data, the three most recent Treasury Shares figures were $3.2 million in Q3 2016, $3.2 million in Q2 2016, and $3.2 million in Q1 2016.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - | 17.69 Mn |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn | - |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | - |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | - |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - | - |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | - |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn | 655,642.00 |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn | - |
| 10 | Taysha Gene Therapies | 1.97 Bn | 1.97 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2016 | 3.15 Mn |
| Sep 30, 2016 | 3.15 Mn |
| Jun 30, 2016 | 3.15 Mn |
| Jun 30, 2016 | 3.15 Mn |
| Mar 31, 2016 | 3.15 Mn |
| Mar 31, 2016 | 3.15 Mn |
| Dec 31, 2015 | 1.25 Mn |
| Dec 31, 2015 | 3.15 Mn |
| Dec 31, 2015 | 1.25 Mn |
| Dec 31, 2015 | 3.15 Mn |
| Dec 31, 2014 | 1.25 Mn |
| Dec 31, 2014 | 1.25 Mn |
| Jun 30, 2013 | 12,000.00 |
| Jun 30, 2013 | 12,000.00 |
| Mar 31, 2013 | 12,000.00 |
| Mar 31, 2013 | 12,000.00 |
| Dec 31, 2012 | 12,000.00 |
| Dec 31, 2012 | 12,000.00 |
| Sep 30, 2012 | 12,000.00 |
| Sep 30, 2012 | 12,000.00 |